CVS Suspends Sale Of Zantac Over Possible Cancer Link

September 30, 2019 By News Staff Health 0

CVS Suspends Sale Of Zantac Over Possible Cancer Link. File image.

WOONSOCKET, RI – CVS Pharmacy is pulling a heartburn drug off the shelves over cancer concerns.

The pharmacy chain says it has stopped selling Zantac and its own generic version of the medication.

The move comes after the U.S. Food and Drug Administration said acid-reducing medicines with ranitidine contain low levels of an impurity that could cause cancer.


Despite CVS’s decision to stop selling the medicine, Zantac and its generic counterpart have not been recalled.

But, CVS says customers who have already bought the products can return them for a refund.

 



Make it easy to keep up to date with more stories like this. Download the WNY News Now mobile app on the Apple App Store and Google Play Store.

 

Have a news tip? Email newsdesk@WNYNewsNow.com, send us a message on Facebook, or Twitter.

WNY News Now encourages an open exchange of opinions and ideas on our stories, however, we ask everyone to follow our comment policy.

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.